ACSL4 and cancer: According to previous studies, ACSL4 promotes ferroptosis sensitivity by synthesizing PUFA [39], and pharmacological inhibiting of ACSL4 with thiazolidinediones has been shown to prevent cancer tissue demise in a murine model of ferroptosis [11].